For the Inventor, By the Inventor

Enter assignee name

Memphis, TN, United States of America

St. Jude Children's Research Hospital

USPTO Granted Patents = 260

CIPO Patents = 40

EPO Patents = 35

Trademarks = 3

Forward Citations = 2,729

Loading Chart...

Loading Chart...

419 inventors (with patents filed for the assignee):

Dario Campana (22 out of 36 patents)

Robert G Webster (19 out of 19 patents)

Elaine I Tuomanen (15 out of 31 patents)

4. Richard Edward Lee (12 out of 21 patents)

5. Richard John Webby (12 out of 12 patents)

6. Charles J Sherr (11 out of 12 patents)

7. Amit Nathwani (10 out of 27 patents)

8. Edward Tuddenham (10 out of 12 patents)

9. Andrew Davidoff (10 out of 10 patents)

10. Jaeki Min (9 out of 11 patents)

11. Taosheng Chen (9 out of 9 patents)

12. Erich Hoffmann (9 out of 13 patents)

13. John T Gray (8 out of 11 patents)

14. R Kiplin Guy (8 out of 8 patents)

15. Stephan W Morris (8 out of 8 patents)

Core Competencies:

Nucleic Acid Molecules

Chimeric Antigen Receptors

Cereblon Protein Modulators

Natural Killer Cells

Adeno-Associated Virus

Inflammasome Activation

Gene Modifications

Immunogenic Fusion Proteins

T Cell Immune Response

Hearing Loss Treatment

Bromodomain Inhibitors

Metabolic Reprogramming

260 patents: Sort by Forward Citations

1. 12454519 - Substituted N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)arylsulfonamide analogs as modulators of cereblon protein (2025-10-28),

2. 12454518 - Substituted N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)arylsulfonamide analogs as modulators of cereblon protein (2025-10-28),

3. 12453783 - Nucleic acid molecules containing spacers and methods of use thereof (2025-10-28),

4. 12448426 - Chimeric antigen receptors with MYD88 and CD40 costimulatory domains (2025-10-21),

5. 12409171 - Pharmaceutically active pyrazolo-pyridone modulators of DCN1/2-mediated cullin neddylation (2025-09-09),

6. 12372526 - Method for identifying modulators of G3BP activity (2025-07-29),

7. 12318391 - Methods and compositions for the prevention and treatment of hearing loss (2025-06-03),

8. 12297427 - Cloning and expression system for T-cell receptors (2025-05-13),

9. 12264335 - Natural killer cells expressing membrane-bound interleukin 15 (mbIL15) and uses thereof (2025-04-01),

10. 12263177 - Biologically active ganoderma lucidum compounds and synthesis of anticancer derivatives; ergosterol peroxide probes for cellular localization (2025-04-01),

11. 12257319 - Optimised coding sequence and promoter (2025-03-25),

12. 12239692 - Adeno-associated virus factor VIII vectors (2025-03-04),

13. 12234480 - Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cells (2025-02-25),

14. 12161671 - Immune cells with DNMT3A gene modifications and methods related thereto (2024-12-10),

15. 12053490 - Methods and compositions for treating CD33+ cancers and improving in vivo persistence of chimeric antigen receptor T cells (2024-08-06),

St. Jude Children's Research Hospital is a leading pediatric treatment and research facility. As a world-renowned healthcare institution, St. Jude is dedicated to advancing cures, saving children, and sharing its knowledge globally. Their commitment extends to patient care, scientific research, and finding cure for childhood cancer and other life-threatening diseases. Through innovative research and compassionate care, St. Jude continues to impact the lives of children and families worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

260 Patents

#5 in Memphis, TN

#14 in Tennessee

#1,585 in US

#3,245 in the World

Memphis, TN, United States of America

St. Jude Children's Research Hospital

Forward Citations = 2,729

419 inventors:

Dario Campana (22 out of 36 patents)

Robert G Webster (19 out of 19 patents)

Elaine I Tuomanen (15 out of 31 patents)

4. Richard Edward Lee (12 out of 21 patents)

5. Richard John Webby (12 out of 12 patents)

Please report any incorrect information to support@idiyas.com

Loading…